130 related articles for article (PubMed ID: 33851571)
1. Cost burden of post-transplant lymphoproliferative disease following kidney transplants in Medicare-eligible patients by survival status.
Hart A; Ahn YS; Watson C; Skeans M; Barlev A; Thompson B; Dharnidharka VR
J Med Econ; 2021; 24(1):620-627. PubMed ID: 33851571
[TBL] [Abstract][Full Text] [Related]
2. Retrospective database analysis of healthcare resource utilization and costs in patients who develop post-transplant lymphoproliferative disease within the first year following allogeneic hematopoietic stem cell transplants.
Watson C; Xu H; Princic N; Sruti I; Barlev A
J Med Econ; 2020 Oct; 23(10):1159-1167. PubMed ID: 32643493
[TBL] [Abstract][Full Text] [Related]
3. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
Kasiske BL; Kukla A; Thomas D; Wood Ives J; Snyder JJ; Qiu Y; Peng Y; Dharnidharka VR; Israni AK
Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332
[TBL] [Abstract][Full Text] [Related]
4. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
5. Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipients.
Zierhut H; Kanzelmeyer N; Buescher A; Höcker B; Mauz-Körholz C; Tönshoff B; Metzler M; Pohl M; Pape L; Maecker-Kolhoff B
Pediatr Transplant; 2021 Sep; 25(6):e14042. PubMed ID: 34021949
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey.
Khedmat H; Taheri S
Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272
[TBL] [Abstract][Full Text] [Related]
7. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients.
Francis A; Johnson DW; Craig J; Teixeira-Pinto A; Wong G
Kidney Int; 2018 Oct; 94(4):809-817. PubMed ID: 30173897
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant lymphoproliferative disorder: no relationship to recombinant human growth hormone use in Australian and New Zealand pediatric kidney transplant recipients.
Longmore DK; Conwell LS; Burke JR; McDonald SP; McTaggart SJ
Pediatr Transplant; 2013 Dec; 17(8):731-6. PubMed ID: 24164826
[TBL] [Abstract][Full Text] [Related]
10. Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk.
Dharnidharka VR; Tejani AH; Ho PL; Harmon WE
Am J Transplant; 2002 Nov; 2(10):993-8. PubMed ID: 12482154
[TBL] [Abstract][Full Text] [Related]
11. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ
Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N
Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.
Quinlan SC; Pfeiffer RM; Morton LM; Engels EA
Am J Hematol; 2011 Feb; 86(2):206-9. PubMed ID: 21264909
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.
Maksten EF; Vase MØ; Kampmann J; d'Amore F; Møller MB; Strandhave C; Bendix K; Bistrup C; Thiesson HC; Søndergaard E; Hamilton-Dutoit S; Jespersen B
Transpl Int; 2016 Apr; 29(4):483-93. PubMed ID: 26749337
[TBL] [Abstract][Full Text] [Related]
15. Incidence of post-transplantation lymphoproliferative disease in Andalusia (1990-2009).
Govantes MA; Esteve AF; Ramos MT; Gracia De Guindo MC; Sánchez LF; Blanca MA; Rodríguez-Benot A; Blandino MV; De la Nuez PC; Rodríguez DB
Transplant Proc; 2013; 45(10):3592-4. PubMed ID: 24314968
[TBL] [Abstract][Full Text] [Related]
16. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.
Caillard S; Porcher R; Provot F; Dantal J; Choquet S; Durrbach A; Morelon E; Moal V; Janbon B; Alamartine E; Pouteil Noble C; Morel D; Kamar N; Buchler M; Mamzer MF; Peraldi MN; Hiesse C; Renoult E; Toupance O; Rerolle JP; Delmas S; Lang P; Lebranchu Y; Heng AE; Rebibou JM; Mousson C; Glotz D; Rivalan J; Thierry A; Etienne I; Moal MC; Albano L; Subra JF; Ouali N; Westeel PF; Delahousse M; Genin R; Hurault de Ligny B; Moulin B
J Clin Oncol; 2013 Apr; 31(10):1302-9. PubMed ID: 23423742
[TBL] [Abstract][Full Text] [Related]
17. Posttransplant Lymphoproliferative Disorder in Adults Receiving Kidney Transplantation in British Columbia: A Retrospective Cohort Analysis.
Ready E; Chernushkin K; Partovi N; Hussaini T; Luo C; Johnston O; Shapiro RJ
Can J Kidney Health Dis; 2018; 5():2054358118760831. PubMed ID: 29636980
[TBL] [Abstract][Full Text] [Related]
18. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland.
Steiner R; Kridel R; Giostra E; McKee T; Achermann R; Mueller N; Manuel O; Dickenmann M; Schuurmans MM; de Leval L; Fehr T; Tinguely M; Binet I; Cogliatti S; Haralamvieva E; Koller M; The Swiss Transplant Cohort Study Stcs ; Dietrich PY
Swiss Med Wkly; 2018; 148():w14596. PubMed ID: 29518251
[TBL] [Abstract][Full Text] [Related]
19. Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: Analysis of ISHLT Registry.
Zaffiri L; Long A; Neely ML; Cherikh WS; Chambers DC; Snyder LD
J Heart Lung Transplant; 2020 Oct; 39(10):1089-1099. PubMed ID: 32654913
[TBL] [Abstract][Full Text] [Related]
20. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study.
Francis A; Johnson DW; Teixeira-Pinto A; Craig JC; Wong G
Nephrol Dial Transplant; 2018 May; 33(5):881-889. PubMed ID: 29342279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
